Effect and mechanism of epidermal growth factor on proliferation of GL15 gliomas cell line

Abstract

The effects of epidermal growth factor (EGF) on proliferation of G15 glioma cells and the possible mechanisms were investigated. GFAP and EGFR expression was detected by immunohistochemical method. After the cells were treated with EGF at different concentrations, cell count method was used to determine the proliferation of glioma cells, cell cycle and apoptosis were analyzed by flow cytometry (FCM), and laser scan confocal microscope (LSCM) was used to measure the cytoplasmic free calcium. The results showed that GFAP was diffusedly expressed in GL15 cells and EGFR was over-expressed. EGF at doses of ≤1 ng/mL could significantly stimulate cell proliferation, cells in phase G₀/G₁ decreased, and those in phase S increased. EGF at doses of 10 and 100ng/ml could inhibit the cell proliferation significantly, and the apoptosis ratio in high dose of EGF group was higher than in control group. EGF could significantly induce a quick rise of intracellular free calcium, but the peak value of intracellular free calcium activated by high dose of EGF was higher than by low dose of EGF. It was suggested that EGF had a dual effect on gliomas: low dose of EGF could stimulate the cell proliferation of gliomas, but high dose of EGF could induce the cell apoptosis and inhibit the proliferation of gliomas, which might be contributed to the difference of intracellular free calcium.

Keywords

epidermal growth factor / GL15 cell line / proliferation / intracellular free calcium / apoptosis

References

[1] ThomasC., ElyG., JamesC. D., et al.. Glioblastoma-related gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells. Acta Neuropathol (Berl), 2001, 101(6): 605-615

[2] LaurentN., de BouardS., GuillamoJ. S., et al.. Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo. Mol Cancer There, 2004, 3(2): 129-136

[3] AldapeK. D., BallmanK., FurthA., et al.. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol, 2004, 63(7): 700-707

[4] PollackI. F., RandallM. S., KristofikM. P., et al.. Response of malignant glioma cell lines to epidermal growth factor and platelet-derived growth factor in a serum-free medium. J Neurosurg, 1990, 73(1): 106-112

[5] O’RourkD. M., NuteE. J., DavisJ. G., et al.. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly. Oncogene, 1998, 16(9): 1197-1207

[6] BryantJ. A., FinnR. S., SlamonD. J., et al.. EGF activates intracellular and intercellular calcium signaling by distinct pathways in tumor cells. Cancer Biol Ther, 2004, 3(12): 1243-1249

[7] LiuZ. Q., ZhengJ. Z., ChenY. Q., et al.. The effect of calcium on brain ischemia-reperfusion injury. J Apop Derv Dise (Chinese), 1990, 7(3): 131-132

[8] CohenO., KimchiA.. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ, 2001, 8(1): 6-15

[9] CohenO., InbalB., KissilJ. L., et al.. DAP-kinase participates in TNF-alpha-and Fas-induced apoptosis and its function requires the death domain. J Cell Biol, 1999, 146(1): 141-148

[10] PuY., LuoK. Q., ChangD. C.. A Ca²⁺ signal is found upstream of cytochrome C release during apoptosis in Hela cells. Biochem Biophys Res Commun, 2002, 299(5): 762-769